Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | PLG | P00747 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.55 |
| ▸ | KDM1A | O60341 | 9/20 | 0.50 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17730485 | 1.00 | F2 (0.55) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL8312824 | 1.00 | F2 (0.55) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL31650872 | 1.00 | F2 (0.55) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL20114738 | 0.83 | F2 (0.55) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL17354740 | 0.81 | F2 (0.53) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL18891443 | 0.79 | PBRM1 (0.55) | F2PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL750859 | 0.78 | KDM1A (0.59) | KDM1ARECQLCYP3A4CA12ALDH1A1 | |
| SCHEMBL8820938 | 0.78 | KDM1A (0.59) | KDM1ARECQLCYP3A4CA12ALDH1A1 | |
| SCHEMBL750858 | 0.78 | KDM1A (0.59) | KDM1ARECQLCYP3A4CA12ALDH1A1 | |
| SCHEMBL31748645 | 0.78 | KDM1A (0.59) | KDM1ARECQLCYP3A4CA12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140026782-A1 | SILVER INK COMPOSITION | INKTEC CO., LTD. (KR) | 2014-01-30 | — | — | US | claimed |
| WO-2012144847-A2 | SILVER INK COMPOSITION | 주식회사 잉크테크 (KR) | 2012-10-26 | — | — | WO | claimed |
| US-12501540-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12451440-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| US-12389549-B2 | Manufacturing method of electronic device | FUJIFILM CORPORATION (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250236954-A1 | MANUFACTURING METHOD OF CONDUCTIVE FILM AND MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY | FUJIFILM CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| CN-119866391-A | Method for producing conductive film and method for producing electromagnetic wave shield | 富士胶片株式会社 | 2025-04-22 | — | — | CN | disclosed |
| US-20240425715-A1 | MANUFACTURING METHOD OF CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240424817-A1 | MANUFACTURING METHOD OF CONDUCTOR, MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY, AND CONDUCTOR | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240414839-A1 | MANUFACTURING METHOD OF PRINTED CIRCUIT BOARD | FUJIFILM CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| CN-118900778-A | Method for manufacturing conductive layer | 富士胶片株式会社 | 2024-11-05 | — | — | CN | disclosed |
| EP-1944305-B1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LTD (GB) | 2011-10-19 | — | — | EP | disclosed |
| US-20090312325-A1 | Quinoline Derivatives As Phosphodiesterase Inhibitors | BALDWIN IAN ROBERT | 2009-12-17 | — | — | US | disclosed |
| US-7572915-B2 | 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; asthma, COPD, allergic rhinitis, or rheumatoid arthritis in a human | GLAXO GROUP LIMITED (GB) | 2009-08-11 | — | — | US | disclosed |
| US-7566786-B2 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2009-07-28 | — | — | US | disclosed |
| EP-1944305-A1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2008-07-16 | — | — | EP | disclosed |
| EP-1633748-B1 | QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | GLAXO GROUP LTD (GB) | 2008-03-05 | — | — | EP | disclosed |
| US-20070142373-A1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2007-06-21 | — | — | US | disclosed |
| US-20070049570-A1 | Quinoline derivatives as phosphodiesterase inhibitors | DEAN ANTHONY W | 2007-03-01 | — | — | US | disclosed |
| US-20060178416-A1 | Quinoline derivatives as phosphodiesterase inhibitors | BARKER MICHAEL D | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178416-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | F2 2108/4885PLG 2110/4885PRSS1 171/4885 |
| US-20090312325-A1 | Quinoline Derivatives As Phosphodiesterase Inhibitors | PDE3B, PDE4B, PDE4A | F2 2108/4885PLG 2110/4885PRSS1 171/4885 |
| US-20070049570-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | F2 2108/4885PLG 2110/4885PRSS1 171/4885 |
| US-20070142373-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | F2 2108/4885PLG 2110/4885PRSS1 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.